Comparison of two tranexamic acid dose regimens in patients undergoing cardiac valve surgery

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 28, Issue 5, 2014, Pages 1233-1237

  Du, Yingjie ^a   Xu, Jiaying ^b   Wang, Guyan ^a   Shi, Jia ^a   Yang, Lijing ^a   Shi, Sheng ^a   Lu, Haisong ^a   Wang, Yuefu ^a   Ji, Bingyang ^a   Zheng, Zhe ^a  

^a FUWAI HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

fibrinolysis; heart valve diseases; hemorrhage; hemostasis; tranexamic acid

Indexed keywords

TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; ALLOGENEIC BLOOD TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CHINA; COMPARATIVE STUDY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HEART VALVE SURGERY; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ADVERSE EFFECTS; FOLLOW UP; MIDDLE AGED;

ADULT; ANTIFIBRINOLYTIC AGENTS; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84908243385     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.10.006     Document Type: Article

References (37)

1. G.J. Murphy, B.C. Reeves, and C.A. Rogers Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery Circulation 116 2007 2544 2552
2. B.C. Reeves, and G.J. Murphy Increased mortality, morbidity, and cost associated with red blood cell transfusion after cardiac surgery Current opinion in cardiology 23 2008 607 612
3. D.T. Mangano, I.C. Tudor, and C. Dietzel The risk associated with aprotinin in cardiac surgery N Engl J Med 354 2006 353 365
4. A.D. Shaw, M. Stafford-Smith, and W.D. White The effect of aprotinin on outcome after coronary-artery bypass grafting N Engl J Med 358 2008 784 793
5. S. Schneeweiss, J.D. Seeger, and J. Landon Aprotinin during coronary-artery bypass grafting and risk of death N Engl J Med 358 2008 771 783
6. D.A. Fergusson, P.C. Hebert, and C.D. Mazer A comparison of aprotinin and lysine analogues in high-risk cardiac surgery N Engl J Med 358 2008 2319 2331
7. J.R. Brown, N.J.O. Birkmeyer, and G.T. O'Connor Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery Circulation 115 2007 2801 2813
8. D.A. Henry, P.A. Carless, and A.J. Moxey Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion Cochrane Database Syst Rev 2011 CD001886
9. J. Martin, and D. Cheng Tranexamic acid for routine use in off-pump coronary artery bypass surgery Anesthesia & Analgesia 115 2012 227 230
10. V.A. Ferraris, J.R. Brown, and G.J. Despotis 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines The Annals of thoracic surgery 91 2011 944 982
11. A.H. Menkis, J. Martin, and D.C.H. Cheng Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: A consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ismics) 2011 Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 7 2012 229 241
12. N.P. Dowd, J.M. Karski, and D.C. Cheng Pharmacokinetics of tranexamic acid during cardiopulmonary bypass Anesthesiology 97 2002 390 399
13. A. Koster, and U. Schirmer Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era Current Opinion in Anaesthesiology 24 2011 92 97
14. D.L. Ngaage, and J.M. Bland Lessons from aprotinin: Is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies Eur J Cardiothorac Surg 37 2010 1375 1383
15. M.A. Fox Tranexamic acid: How much is enough? Anesth Analg 111 2010 580 581 author reply 581
16. T. Waldow, K. Plotze, and K. Matschke Low-dose tranexamic acid is best regimen for elective cardiac surgery patients to prevent hyperfibrinolysis Hamostaseologie 32 2012 A13
17. I. Lecker, B.A. Orser, and C.D. Mazer "Seizing" the opportunity to understand antifibrinolytic drugs Can J Anaesth 59 2012 1 5
18. V. Sharma, J. Fan, and A. Jerath Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass Anaesthesia 67 2012 1242 1250
19. L. Andersson, I.M. Nilsoon, and S. Colleen Role of urokinase and tissue activator in sustaining bleeding and the management thereof with eaca and amca Ann N Y Acad Sci 146 1968 642 658
20. G. Soslau, J. Horrow, and I. Brodsky Effect of tranexamic acid on platelet adp during extracorporeal circulation Am J Hematol 38 1991 113 119
21. G.A. Nuttall, M.C. Gutierrez, and J.D. Dewey A preliminary study of a new tranexamic acid dosing schedule for cardiac surgery J Cardiothorac Vasc Anesth 22 2008 230 235
22. K. Martin, G. Wiesner, and T. Breuer The risks of aprotinin and tranexamic acid in cardiac surgery: A one-year follow-up of 1188 consecutive patients Anesth Analg 107 2008 1783 1790
23. J.M. Murkin, F. Falter, and J. Granton High-dose tranexamic acid is associated with nonischemic clinical seizures in cardiac surgical patients Anesth Analg 110 2010 350 353
24. C. Keyl, R. Uhl, and F. Beyersdorf High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement Eur J Cardiothorac Surg 39 2011 e114 e121
25. M. Berman, D. Cardone, and L. Sharples Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: Review of 200 patients Ann Thorac Surg 90 2010 1432 1436
26. R.A. Manji, H.P. Grocott, and J. Leake Seizures following cardiac surgery: The impact of tranexamic acid and other risk factors Can J Anaesth 59 2012 6 13
27. D. Bell, S. Marasco, and A. Almeida Tranexamic acid in cardiac surgery and postoperative seizures: A case report series Heart Surg Forum 13 2010 E257 E259
28. K. Martin, J. Knorr, and T. Breuer Seizures after open heart surgery: Comparison of ε-aminocaproic acid and tranexamic acid J Cardiothorac Vasc Anesth 25 2011 20 25
29. D. Kalavrouziotis, P. Voisine, and S. Mohammadi High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass Ann Thorac Surg 93 2012 148 154
30. A. Koster, J. Borgermann, and A. Zittermann Moderate dosage of tranexamic acid during cardiac surgery with cardiopulmonary bypass and convulsive seizures: Incidence and clinical outcome Br J Anaesth 110 2013 34 40
31. M. Sander, C.D. Spies, and V. Martiny Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: A retrospective analysis Crit Care 14 2010 R148
32. D. Royston Tranexamic acid in cardiac surgery: Is there a cause for concern? Crit Care 14 2010 194
33. R. Furtmuller, M.G. Schlag, and M. Berger Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a gamma-aminobutyric acid(a) receptor antagonistic effect J Pharmacol Exp Ther 301 2002 168 173
34. I. Lecker, D.S. Wang, and A.D. Romaschin Tranexamic acid concentrations associated with human seizures inhibit glycine receptors J Clin Invest 122 2012 4654 4666
35. S. Grassin-Delyle, B. Tremey, and E. Abe Population pharmacokinetics of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass Br J Anaesth Epub 2013
36. J.C. Horrow, D.F. Van Riper, and M.D. Strong The dose-response relationship of tranexamic acid Anesthesiology 82 1995 383 392
37. S. Sigaut, B. Tremey, and A. Ouattara Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass Anesthesiology. Epub 2013 Jul 30